Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the ...

In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine. ...

President Joe Biden speaks about reaching 300 million COVID-19 vaccination shots, in the State Dining Room of the White House, Friday, June 18, ...

People without mask walk at Times Square on May 19, 2021 in New York City. John Smith | Corbis News | Getty Images ...

Funeral workers wearing personal protective equipment carry a casket during the burial of a COVID-19 victim, amid a nationwide coronavirus disease (COVID-19) lockdown, ...

Dr. Peter Hotez warned that Southern U.S. states could feel the impact of the highly transmissible Delta Covid variant as early as this ...

chameleonseye | iStock | Getty Images Suicide attempts surged among 12- to 17-year-olds, especially adolescent girls, during the Covid-19 pandemic and got worse ...

U.S. Sen. Bob Casey, right, looks on as Dr. Paul Offit, speaks during a news conference Friday, Feb. 13, 2015, in Philadelphia. Matt ...

Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying ...

Dr. Anthony Fauci, Director at the National Institute Of Allergy and Infectious Diseases attends a U.S. Senate Health, Education, Labor, and Pensions Committee ...